|
KATNA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18190002229568E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.777490E-03 |
| Normal-vs-Stage2 |
1.605870E-04 |
| Normal-vs-Stage3 |
2.22633023128083E-12 |
| Normal-vs-Stage4 |
1.0678999995406E-07 |
| Stage1-vs-Stage2 |
2.362300E-02 |
| Stage1-vs-Stage3 |
6.8659999996612E-07 |
| Stage1-vs-Stage4 |
1.602180E-03 |
| Stage2-vs-Stage3 |
2.361400E-01 |
| Stage2-vs-Stage4 |
7.373400E-01 |
| Stage3-vs-Stage4 |
3.420600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.282900008448E-09 |
| Normal-vs-AfricanAmerican |
2.164200E-03 |
| Normal-vs-Asian |
3.581800E-01 |
| Caucasian-vs-AfricanAmerican |
9.074000E-01 |
| Caucasian-vs-Asian |
6.139200E-01 |
| AfricanAmerican-vs-Asian |
6.817400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61735078055381E-12 |
| Normal-vs-Female |
4.803200E-03 |
| Male-vs-Female |
1.188900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.036700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.03529999995189E-06 |
| Normal-vs-Age(61-80Yrs) |
2.27130000363118E-08 |
| Normal-vs-Age(81-100Yrs) |
1.340210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.496400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.232600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.512400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.753200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.059400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.341560E-01 |
| Normal-vs-Grade 2 |
2.878000E-03 |
| Normal-vs-Grade 3 |
7.64770469174891E-11 |
| Normal-vs-Grade 4 |
4.90718576884319E-14 |
| Grade 1-vs-Grade 2 |
7.722700E-03 |
| Grade 1-vs-Grade 3 |
7.84850000000725E-05 |
| Grade 1-vs-Grade 4 |
1.53570000049896E-07 |
| Grade 2-vs-Grade 3 |
1.249000E-04 |
| Grade 2-vs-Grade 4 |
8.10430000885987E-09 |
| Grade 3-vs-Grade 4 |
3.781800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.635400E-01 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.62130000045136E-07 |
| Normal-vs-N1 |
9.89799999999708E-05 |
| N0-vs-N1 |
8.222700E-03 |
|
|
